MedPath

Multi-center phase ? clinical trial of Qinxiang Qingjie Oral Liquid for treating pediatric patients of acute upper respiratory infection with syndrome of heat in both exterior and interior

Phase 3
Completed
Conditions
Acute upper respiratory infection with the syndrome of heat in both exterior and interior
Registration Number
ITMCTR2200005578
Lead Sponsor
FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Meet the western diagnostic criteria for acute upper respiratory tract infection;
2.Conforming to the standard of syndrome differentiation of both external and internal heat syndromes;
3.The ages ranged from 6 months to 14 years;
4.The course of the disease was less than 48 hours.
5.The parent or guardian signed the informed consent.

Exclusion Criteria

1.Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
2.Suppurative tonsillitis, bronchitis, bronchiolitis, pneumonia and other diseases;
3.Severe malnutrition, rickets;
4.Persons under 3 years of age with a history of febrile convulsions;
5.Allergic to known components of this preparation;
6.According to the doctor's judgment, easy to cause lost visitors

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease curative effect;he time when the body temperature returns to normal;TCM syndrome changes;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath